Ann Neurol

1. VOIGT RM, Keshavarzian A, Hall DA
   Fecal Microbiota Transplant in Parkinson's Disease: Insights into the Gut-Brain Axis and the Challenge of Sustained Response.
   Ann Neurol. 2026 Jun 25. doi: 10.1002/ana.78259.
   

   >> Share

   
   

   
   BMC Neurol

2. DA SILVA RO, de Sousa Fontenele LG, Meira OT, Nunes JPA, et al
   Sex difference in Parkinson's disease hospitalization rates in Brazil (2010-2024).
   BMC Neurol. 2026 Jun 20. doi: 10.1186/s12883-026-05102.
   

   >> Share

   
   
3. FENG Y, Zhang R, Wen G, Xie L, et al
   The role of gut microbiota tyrosine decarboxylases in levodopa pharmacokinetics: insights from a levodopa challenge test.
   BMC Neurol. 2025;25:460.
   

   >> Share

   
   
4. CHEN J, Li L, Tian X, Guo X, et al
   The correlation between RLS and motor or other non-motor symptoms of PD patients: an observational study.
   BMC Neurol. 2025;25:298.
   

   >> Share

   
   

   
   Brain Res

5. BRAUN A, Vo PT, Bobrovskaya L
   Progressive orexin A positive neuron loss in the 6-OHDA mouse model of Parkinson's disease: a pilot study with validation of an orexin A immunohistochemistry protocol for paraffin-embedded tissue.
   Brain Res. 2026;1888:150437.
   

   >> Share

   
   

   
   Exp Neurol

6. HASTINGS N, Rahman S, Kuan WL, Alfaidi M, et al
   Roles of astrocytic Connexin 43 gap junctional deficit in alpha-synucleinopathy and inflammation relevant to Parkinson's.
   Exp Neurol. 2026 Jun 26:115897. doi: 10.1016/j.expneurol.2026.115897.
   

   >> Share

   
   

   
   J Clin Psychopharmacol

7. TORUN A, Boyraz N, Toksoy F, Poyraz BC, et al
   Serotonin Syndrome Associated With Polypharmacy in an Elderly Patient With Dementia and Parkinson Disease.
   J Clin Psychopharmacol. 2026;46:490-492.
   

   >> Share

   
   

   
   Lancet

8. THE EDITORS OF THE LANCET
   Expression of Concern: Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.
   Lancet. 2026;407:2588.
   

   >> Share

   
   

   
   Mov Disord

9. XU Y, Yin Z, Fan H, Bai Y, et al
   Dual Oscillatory Signatures in Pallidal Circuits Underlie Symptom Complexity in Huntington's Disease Patients.
   Mov Disord. 2026;41:1413-1426.
   

   >> Share

   
   

   
   Nat Med

10. BALACHANDAR A, Fasano A
    Adaptive brain stimulation 2.0 for Parkinsonian gait.
    Nat Med. 2026 Jun 26. doi: 10.1038/s41591-026-04489.
    

    >> Share

    
    

    
    Neurobiol Dis

11. BERNARD K, Corenblum MJ, Tonino P, Madhavan L, et al
    Corrigendum to "Bioenergetic And Protein Processing Imbalances in iPSC-Dopamine Neurons from Individuals with Idiopathic Parkinson's Disease" [Neurobiology of Disease 218 (2026) Epub/107222].
    Neurobiol Dis. 2026 Jun 25:107504. doi: 10.1016/j.nbd.2026.107504.
    

    >> Share

    
    

    
    Neurol Clin Pract

12. SEABURY J, Weinstein J, Rosero SJ, Varma A, et al
    Patient-Reported Symptom Burden in Individuals With Parkinson Disease.
    Neurol Clin Pract. 2026;16:e200632.
    

    >> Share

    
    

    
    Neurology

13. ADLER CH, Janarthanam C, Serrano GE, Anantharam V, et al
    Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson Disease.
    Neurology. 2026;107:e218121.
    

    >> Share

    
    

    
    Neuroscience

14. HUANG C, Tan C, Shen Q, Liu Q, et al
    Disrupted brain functional network topology and potential network reorganization in early-stage Parkinson's disease with probable REM sleep behavior disorder.
    Neuroscience. 2026 Jun 25:S0306-4522(26)00423.
    

    >> Share

    
    
15. ROHR-FUKUMA M, Stieglitz LH, Bujan B, Imbach LL, et al
    Explorative investigation on effects of multi-day neurofeedback with implanted electrodes in patients with Parkinson's disease.
    Neuroscience. 2026 Jun 24:S0306-4522(26)00391.
    

    >> Share

    
    
16. SHALABI MG, Al-Kuraishy HM, Shokr MM, Batiha GE, et al
    Molecular crosstalk between MAPK signaling and neuroprotective pathways in Parkinson's disease: from pathogenesis to therapeutic potential.
    Neuroscience. 2026;610:297-310.
    

    >> Share

    
    

    
    PLoS One

17. KACAMAK P, Elmas C, Tokcaer Bora HA, Babaoglu Aydas SS, et al
    Investigation of correlation between cholesterol intake, apolipoprotein B and Parkinson's disease related genes in guinea pigs feeding a high-fat diet containing cholesterol.
    PLoS One. 2026;21:e0352642.
    

    >> Share

    
    
18. VAN LEEUWEN AM, Welzel J, D'Ascanio I, Lang C, et al
    Steps against the burden of Parkinson's disease (StepuP): Protocol of a randomized controlled trial elucidating the biomechanical and neurophysiological mechanisms of a speed dependent treadmill training intervention.
    PLoS One. 2026;21:e0348957.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share